KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Charles River Laboratories International (CRL) Assets Average (2016 - 2025)

Historic Assets Average for Charles River Laboratories International (CRL) over the last 17 years, with Q3 2025 value amounting to $7.5 billion.

  • Charles River Laboratories International's Assets Average fell 550.25% to $7.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $7.5 billion, marking a year-over-year decrease of 550.25%. This contributed to the annual value of $7.9 billion for FY2024, which is 47.11% down from last year.
  • Latest data reveals that Charles River Laboratories International reported Assets Average of $7.5 billion as of Q3 2025, which was down 550.25% from $7.6 billion recorded in Q2 2025.
  • Charles River Laboratories International's Assets Average's 5-year high stood at $8.2 billion during Q1 2024, with a 5-year trough of $5.6 billion in Q1 2021.
  • Over the past 5 years, Charles River Laboratories International's median Assets Average value was $7.6 billion (recorded in 2025), while the average stood at $7.4 billion.
  • Per our database at Business Quant, Charles River Laboratories International's Assets Average soared by 3180.12% in 2021 and then crashed by 756.72% in 2025.
  • Charles River Laboratories International's Assets Average (Quarter) stood at $7.0 billion in 2021, then rose by 6.41% to $7.5 billion in 2022, then grew by 5.45% to $7.9 billion in 2023, then fell by 1.71% to $7.8 billion in 2024, then decreased by 2.95% to $7.5 billion in 2025.
  • Its Assets Average stands at $7.5 billion for Q3 2025, versus $7.6 billion for Q2 2025 and $7.6 billion for Q1 2025.